Search

everythinglearnresearchcommunity

for

Search:↓

An imbalance in gut bacteria is linked to skin immune diseases and may affect their outcomes and related health issues.

Some treatments can help hair regrowth in alopecia areata, but none offer a cure, and effectiveness varies.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

A brain-produced steroid causes increased scratching in mice with a skin condition similar to eczema.

Acne is a common skin condition that can be influenced by diet, lifestyle, and hormones, and requires a treatment approach that includes psychological considerations.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

Dupilumab may help hair regrowth in some patients with severe atopic dermatitis, but results vary.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

A 55-year-old woman with several health conditions did not see hair regrowth after a transplant.

Use the least toxic, most specific treatments for skin diseases, considering side effects and individual patient needs.

Psychological factors play a significant role in developing alopecia areata.

Some skin conditions may increase the risk of heart disease, and understanding their connection could lead to better treatments.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Certain surgical methods are better than routine incision for hidradenitis suppurativa, topical clindamycin and acitretin are effective treatments, men with HS have a risk of skin cancer, HS patients are more likely to die from heart problems, and specific genetic markers are linked to treatment response.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Nanoparticles can deliver vaccines through hair follicles, triggering immune responses and providing protection.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Certain small molecules can promote hair growth by activating a cellular cleanup process called autophagy.

Dupilumab treatment reduces Th2-related markers and helps hair growth in alopecia areata, showing Th2's role in the condition.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.

Hemp seed biomaterials may reduce hair loss and improve hair growth.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.